Development and characterization of single domain monoclonal antibody against programmed cell death ligand-1; as a cancer inhibitor candidate. - Oghalaie A; Mahboudi F; Rahimi-Jamnani F; Piri-Gavgani S; Kazemi-Lomedasht F; Hassanzadeh Eskafi A; Shahbazzadeh D; Adeli A; Talebkhan Y; Behdani M (Iranian journal of basic medical sciences, 2022)